The U.S. Food and Drug Administration has asked the makers of six atypical antipsychotic drugs to update product labeling to include a warning about a possible link with diabetes, The Associated Press reported. The atypical antipsychotic drugs includes Zyprexa by Eli Lilly & Co., Clozaril by Novartis, Risperdal by Janssen, Seroquel by AstraZeneca, Geodon by […]
Entries Tagged as 'Risperdal'
FDA: Atypical Antipsychotic Drugs May Increase Diabetes Risk
September 22nd, 2003 · 5 Comments
Tags: Geodon · Risperdal · Seroquel · Zyprexa
Zyprexa, Risperdal and Clozaril May Increase Risk of Pancreatitis
September 3rd, 2003 · 25 Comments
Atypical anti-psychotic drugs Clozaril, Zyprexa and Risperdal may increase a patients’ risk of developing pancreatitis when compared with older drugs like Haldol, according to a new study published in the September issue of the journal Pharmacotherapy.
The analysis was based on 192 cases of pancreatitis reported to the Food and Drug Administration or written up in […]
Study Finds Zyprexa, Risperdal and Seroquel May Increase Diabetes Risk
August 25th, 2003 · No Comments
Zyprexa, Risperdal, and Seroquel may increase a patients’ risk of developing diabetes when compared with older antipsychotic drugs like Haldol, researchers with the Department of Veterans Affairs said yesterday.
New York Times reported that, “Younger patients, under age 54, who took Zyprexa or Risperdal showed the highest risk of developing diabetes.”
The study of U.S. military […]

